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1. Introduction {#irv12407-sec-0006}
===============

Influenza A virus (IAV) infections have a significant clinical impact on domestic swine populations. This is mainly related to acute respiratory disease which is frequently exacerbated by synergistic viral and bacterial co‐infections. Economic losses for the pork producing industry due to swine influenza virus (SIV) infections can be substantial.[1](#irv12407-bib-0001){ref-type="ref"}, [2](#irv12407-bib-0002){ref-type="ref"}, [3](#irv12407-bib-0003){ref-type="ref"}

Swine are susceptible to infection from various IAV subtypes of both mammalian and avian origin. This is due to the expression of cellular glycan moieties (alpha 2‐6 or 2‐3‐linked terminal sialic acids, respectively) in the porcine upper respiratory tract that act as receptors for viral attachment by the haemagglutinin protein (HA) of both avian and mammalian IAV.[4](#irv12407-bib-0004){ref-type="ref"}, [5](#irv12407-bib-0005){ref-type="ref"}, [6](#irv12407-bib-0006){ref-type="ref"} Thus, simultaneous infection of porcine cells with mammalian/human and avian IAV is possible. Such double infections open possibilities for an exchange of genome segments between these viruses (reassortment) and progeny viruses with mixed parental genotypes (reassortants) potentially leading to the emergence of new phenotypic properties. For this reason, pigs have been dubbed *mixing vessels* of IAV.[7](#irv12407-bib-0007){ref-type="ref"}, [8](#irv12407-bib-0008){ref-type="ref"}, [9](#irv12407-bib-0009){ref-type="ref"}, [10](#irv12407-bib-0010){ref-type="ref"} Historically, the evolution of human and porcine influenza viruses has been intimately interlinked over at least one century in that new influenza virus reassortants have emerged in swine populations following trans‐species transmission of IAV from infected humans in the course of human IAV pandemics (so‐called reverse zoonotic transmission).[11](#irv12407-bib-0011){ref-type="ref"} However, direct infection of swine with IAV of purely avian origin has also occurred.[12](#irv12407-bib-0012){ref-type="ref"} In swine, some of these viruses swiftly established porcine‐adapted, independently circulating lineages which reassorted amongst each other. As a result of these processes, a variety of sublineages and genotypes of SIV is now prevalent in swine populations worldwide, but with some geographic restrictions,.[13](#irv12407-bib-0013){ref-type="ref"}, [14](#irv12407-bib-0014){ref-type="ref"} Some of these viruses may have zoonotic potential and can be retransmitted into the human population.[15](#irv12407-bib-0015){ref-type="ref"}, [16](#irv12407-bib-0016){ref-type="ref"}, [17](#irv12407-bib-0017){ref-type="ref"}

Until 2009, the IAV subtypes H1N1, H1N2 and H3N2 circulated in domestic pigs at variable rates in Europe. The current enzootic Eurasian SIV H1N1 lineage is of purely avian origin and was introduced to pigs from unknown bird populations in the late 1970s. These viruses are referred to as "avian‐like" (av) H1N1 and are genetically and antigenically distinct from the "classical" (human 1918‐derived) H1N1 SIVs which continue to circulate in North America and some parts of Asia, but not in Europe.[13](#irv12407-bib-0013){ref-type="ref"}, [18](#irv12407-bib-0018){ref-type="ref"} Reassortment of viruses of the Eurasian H1N1av lineage with human seasonal H3N2 viruses gave rise to the porcine H3N2 lineage in which HA and NA are of human origin, while the other six genome segments are of avian descent.[14](#irv12407-bib-0014){ref-type="ref"} In 1994, an H1N2 reassortant (H1huN2) comprising the HA gene from a human seasonal H1N1 virus, the NA gene from H3N2 human‐like SIV and internal genes from H1N1 avian‐like SIV was first identified in the United Kingdom and subsequently detected in many further European countries.[19](#irv12407-bib-0019){ref-type="ref"} In 2003, a new H1N2 SIV reassortant virus was found in Danish pigs.[20](#irv12407-bib-0020){ref-type="ref"} This H1N2 virus comprised an avian‐like HA gene and an NA from contemporary circulating H3N2 SIV and have since been found in several other European countries.[18](#irv12407-bib-0018){ref-type="ref"} Apart from these dominant enzootic strains, several reassortants between these viruses have been described in Europe, but no sustained spread of such viruses has been reported as yet.[21](#irv12407-bib-0021){ref-type="ref"}

Following the emergence of the human pandemic H1N1 2009 influenza A virus (H1N1pdm), a fourth IAV lineage entered swine populations globally. Pigs were found to be highly susceptible to this virus,[22](#irv12407-bib-0022){ref-type="ref"} and spread within swine populations, independent of human infections, is ongoing. An increasing amount of reassortants between porcine‐adapted enzootic IAV and the H1N1pdm virus have been described. Some of these reassortant lineages, such as the H1pdmN2 lineage reported from Germany, have been in regional circulation for several years now [23](#irv12407-bib-0023){ref-type="ref"} and several retained the so‐called TRIG cassette of internal gene segments of the H1N1pdm virus and therefore may carry substantial zoonotic and even pandemic potential.[16](#irv12407-bib-0016){ref-type="ref"}, [21](#irv12407-bib-0021){ref-type="ref"}

Despite coordinated European research efforts in surveillance of porcine IAV, such as the ESNIP consortium,[18](#irv12407-bib-0018){ref-type="ref"} data on the occurrence, spread and evolution of potentially zoonotic SIV in Europe remain fragmentary. This not only impedes the early detection of emerging SIV reassortants with increased zoonotic potential but may also interfere with the development and updating of efficacious influenza virus vaccines for use in pigs.[2](#irv12407-bib-0002){ref-type="ref"}, [3](#irv12407-bib-0003){ref-type="ref"} A prerequisite for efficient SIV surveillance programmes is sensitive and specific diagnostic methods which allow for high‐throughput analysis. Classically, SIV diagnosis is based on virus isolation in MDCK cells and serological subtype characterization by haemagglutination inhibition (HI) assays. However, this has recently been superseded by IAV‐generic real‐time RT‐PCRs (RT‐qPCR).[24](#irv12407-bib-0024){ref-type="ref"}, [25](#irv12407-bib-0025){ref-type="ref"}, [26](#irv12407-bib-0026){ref-type="ref"}, [27](#irv12407-bib-0027){ref-type="ref"} Molecular subtype characterization has, however, depended on time‐consuming sequencing of fragments of the HA and NA genes or on subtype‐specific, conventional RT‐PCRs.[28](#irv12407-bib-0028){ref-type="ref"}, [29](#irv12407-bib-0029){ref-type="ref"}, [30](#irv12407-bib-0030){ref-type="ref"}

Here we present two multiplex RT‐qPCRs to facilitate the detection and differentiation of four and three lineages of HA and of NA gene segments, respectively, of SIV subtypes which currently cocirculate in European swine populations. In combination with a generic IAV‐specific duplex RT‐qPCR (enhanced by an internal control), we propose a diagnostic algorithm for a rapid, sensitive and lineage‐specific large‐scale monitoring of SIV infections in clinical samples from swine in Europe.

2. Material and Methods {#irv12407-sec-0007}
=======================

2.1. Field samples, reference viruses {#irv12407-sec-0008}
-------------------------------------

Lung tissue samples or nasal swabs derived from pigs with respiratory disease were obtained from swine holdings in several European countries in the frame of a passive monitoring programme. Samples were processed and analysed for SIV RNA by an M‐gene‐specific RT‐qPCR as detailed previously.[31](#irv12407-bib-0031){ref-type="ref"} Viral RNA of SIV‐positive samples was subtyped by molecular means using conventional pan‐HA and pan‐NA RT‐PCRs and amplicon Sanger sequencing.[32](#irv12407-bib-0032){ref-type="ref"}, [33](#irv12407-bib-0033){ref-type="ref"} In addition, virus isolation in MDCK cell cultures was attempted and isolates were subtyped by either full‐length nucleotide sequence analysis of the HA and NA genome segments as described elsewhere [34](#irv12407-bib-0034){ref-type="ref"} or amplicon sequencing of short HA and NA fragments. influenza A viruses of other host species were retrieved from the reference collections at FLI (Friedrich‐Loeffler‐Institut, Greifswald‐Insel Riems, Germany) or RKI (Robert‐Koch‐Institut, Berlin, Germany) and used for RT‐qPCR validation purposes. Similarly, other porcine respiratory pathogens of viral and bacterial nature were used for assessing analytical specificity (Table S1).

2.2. Design of primers and probes {#irv12407-sec-0009}
---------------------------------

Primers and probes for subtype and/or lineage‐specific detection of HA and NA for use in multiplexed RT‐qPCRs were either selected from previously published assays (H1pdm: [35](#irv12407-bib-0035){ref-type="ref"} N1 and N2 (Hoffmann et al.[36](#irv12407-bib-0036){ref-type="ref"} (2016) or manually selected (H1av, H1hu, H3, N1pdm) from alignments comprising full‐length HA and NA sequences of European SIV detected since year 2000; sequences were retrieved from the Influenza Research (IRD) and *Global Initiative on Sharing All Influenza Data* **(**GISAID) databases. Melting temperatures and basic properties of oligonucleotides were approximated using the online tool "Oligocalc".[37](#irv12407-bib-0037){ref-type="ref"} Preliminary versions of the primer and probe sets were evaluated with European SIV isolates previously identified [18](#irv12407-bib-0018){ref-type="ref"} in laboratories in France, Italy, United Kingdom, Denmark and Germany during the ESNIP3 concerted action. Based on these results, further rounds of optimizing oligonucleotide sequences were initiated. Table [1](#irv12407-tbl-0001){ref-type="table-wrap"} lists the final sets of primers and probes for RT‐qPCRs (A) and conventional RT‐PCRs (B).

###### 

Attributes of primers and probes employed in tetra‐ and triplex RT‐qPCRs (A) or in multiplex RT‐PCR (B) for the detection of HA and NA lineages, respectively, of swine influenza viruses currently circulating in Europe

  Primer/Probe          Concentration   Sequence, labelling                                   Location     Product size   Reference sequence
  --------------------- --------------- ----------------------------------------------------- ------------ -------------- ------------------------------------
  \(A\)                                                                                                                   
  *Hemagglutinin*                                                                                                         
  H1av                                                                                                                    
  H1av_Sw_Fn            20 pmol/rxn     gaaggrggatggacaggratra                                1063--1084   134--139 bp    A/swine/Germany/SIV04/2008 (H1N1)
  H1av_Sw_R1            10 pmol/rxn     actgagttcactttgttrytk                                 1176--1196                  FN429078
  H1av_Sw_R2            10 pmol/rxn     caattahtgarttcactttgttgy                              1178--1201                  
  H1av_Sw_HEX_1         2,5 pmol/rxn    HEX‐tctggttaygcagcwgatmagaaaa‐BHQ1                    1126--1150                  
  H1hu                                                                                                                    
  H1hu_Sw_F\_2          10 pmol/rxn     ggatggtacggttaycayca                                  1090--1109   115--208 bp    A/swine/Kitzen/IDT6142/2007 (H1N2)
  H1\[N2\]\_Swine_Fw    10 pmol/rxn     gagggggrtggaccggaatgatagatgga\[i\]5tggttatcatca       1064--1109                  GQ161145
  H1hu_Sw_R\_2          10 pmol/rxn     tttcgatcacagaattcacct                                 1184--1204                  
  H1\[N2\]\_Swine_Rv    10 pmol/rxn     acctacagctgtgaattgagtgttcatyttntcg\[i\]5agagttcacct   1184--1233                  
  H1hu_Sw_ROX           2,5 pmol/rxn    ROX‐cagggwtctgghtatgctgcdgacc‐BHQ2                    1120--1144                  
  H1pdm                                                                                                                   
  H1pdm_Fw              10 pmol/rxn     ctagtggtaccgagatatgca                                 793--813     88 bp          A/Germany‐MV/R26/2011 (pdmH1N1)
  H1pdm_Rv              10 pmol/rxn     tattgcaatcgtggactggtgt                                859--880                    EPI356430
  H1pdm_FAM             1 pmol/rxn      FAM‐cgcaatggaaagaaatgctggatctgg‐BHQ1                  816--842                    
  H3                                                                                                                      
  H3_Sw_F2              10 pmol/rxn     ggggaccctcaytgtga                                     262--278     100 bp         A/swine/Bakum/8602/99 (H3N2)
  H3_Sw_R2              10 pmol/rxn     actcyggcacrtcatahgg                                   343--361                    EF409250
  H3_Sw_Q670            2,5 pmol/rxn    Cy5‐ttgaacgcagcarrgctttcagca‐BHQ3                     311--334                    
  *Neuraminidase*                                                                                                         
  N1all                                                                                                                   
  N1.3_F                12,5 pmol/rxn   agrccttgyttctgggttga                                  1255--1274   126 bp         A/swine/Germany/SIV04/2008 (H1N1)
  N1.3_R                12,5 pmol/rxn   accgtctggccaagacca                                    1363--1380                  FN429079
  AIV_N1.3_FAM          1,5 pmol/rxn    FAM‐atytggacyagtgggagcagcat‐BHQ1                      1306--1328                  
  N1pdm                                                                                                                   
  N1pdm_FW_2            10 pmol/rxn     caacacttgggtaaatcaga                                  174--193     74 bp          A/Germany‐MV/R26/2011 (pdmH1N1)
  N1pdm_RV_2            10 pmol/rxn     cggaaaccactgactgtc                                    230--247                    EPI356429
  N1pdm_SO_2            2,5 pmol/rxn    ROX‐catcagcaacaccaactttgctgct‐BHQ2                    204--228                    
  N2all                                                                                                                   
  N2_1367F              15 pmol/rxn     agtctggtggacytcaaayag                                 1305--1325   116 bp         A/swine/Bakum/8602/99 (H3N2)
  N2_1468R              15 pmol/rxn     ttgcgaaagcttatatagvcatga                              1397--1420                  EF409258
  AIV_N2_1444_HEX       2,5 pmol/rxn    HEX‐ccatcaggccatgagcctgwwccata‐BHQ1                   1357--1382                  
  \(B\)                                                                                                                   
  *panHA* a                                                                                                               
  HA‐1057.1‐F           5 pmol/rxn      ggrgaatgccccaaataygt                                  952--971     180 bp         A/swine/Germany/SIV04/2008 (H1N1)
  HA‐1057.2‐F           5 pmol/rxn      ggraratgccccagrtatgt                                  952--971                    FN429078
  HA‐1057.3‐F           5 pmol/rxn      ggrgaatgccccaartayat                                  952--971                    
  HA‐1232.1(555)‐R      5 pmol/rxn      ctgagtccgaacattgagttgctatgvtgrtawccatacca             1093--1115                  
  HA‐1232.2(555)‐R      5 pmol/rxn      ctgagtccgaacattgagttytgatgyctgaadccrtacca             1093--1115                  
  *panHA‐SIV*                                                                                                             
  H1av                                                                                                                    
  PAN_H1av_DH_F         5 pmol/rxn      ggrgaatgccccaaataygt                                  952--971     180 bp         A/swine/Germany/SIV04/2008 (H1N1)
  PAN_H1av_DH_R\_M13    5 pmol/rxn      cgttgtcgatactggtacttgatgrtgatayccataccayc             1091--1113                  FN429078
  H1hu                                                                                                                    
  PAN_H1hu_DH_F         5 pmol/rxn      ggrgaatgccccaartaygt                                  952--971     180 bp         A/swine/Kitzen/IDT6142/2007 (H1N2)
  PAN_H1hu_DH_R\_M13    5 pmol/rxn      cgttgtcgatactggtaccygrtgatgataaccataccayc             1091--1113                  GQ161145
  H1pdm                                                                                                                   
  PAN_H1pdm_DH_F        5 pmol/rxn      gtgcyataaacaccagcctc                                  902--921     230 bp         A/Germany‐MV/R26/2011 (pdmH1N1)
  PAN_H1pdm_DH_R\_M13   5 pmol/rxn      cgttgtcgatactggtacttgatggtgataaccgtaccatc             1091--1113                  EPI356430
  H3                                                                                                                      
  PAN_H3_DH_F           5 pmol/rxn      aacargatcacatatggrgcatg                               940--962     195 bp         A/swine/Bakum/8602/99 (H3N2)
  PAN_H3_DH_R\_M13      5 pmol/rxn      cgttgtcgatactggtacttgrtgyctgaaaccgtaccarc             1094--1116                  EF409250
  *panNA* a                                                                                                               
  NA‐886.1‐F            10 pmol/rxn     atcgargartgytcntgyta                                  826--845     631 bp         A/swine/Germany/SIV04/2008 (H1N1)
  NA‐886.2‐F            10 pmol/rxn     gtcgargartgytchtgbta                                  826--845                    FN429079
  AIVR‐1458‐R           10 pmol/rxn     gcagtatatcgcttgacaagtagaaacaagg                       1426--1438                   

^a^Gall et al.[33](#irv12407-bib-0033){ref-type="ref"}, 2009.

rxn---volume reaction of 25 μL.

John Wiley & Sons, Ltd

2.3. One‐step RT‐qPCR {#irv12407-sec-0010}
---------------------

The AgPath‐ID^TM^ One‐Step RT‐PCR kit (Ambion, Foster City, CA, USA) was used throughout. Thermocycling conditions on a Bio‐Rad CFX96 real‐time PCR detection system were optimized by adapting annealing time and temperature. These cycling conditions were found to be optimal for the generic M‐specific RT‐qPCR[38](#irv12407-bib-0038){ref-type="ref"}:

10 minutes 45°C, 10 minutes 95°C, 42 cycles each of 15 seconds 95°C -- 20 seconds 55°C -- 30 seconds 72°C.

The cycling conditions for the multiplex HA‐ and NA‐specific RT‐qPCRs were found to be optimal at:

10 minutes 45°C, 10 minutes 95°C, 42 cycles each of 15 seconds 95°C -- 30 seconds 58°C -- 30 seconds 72°C.

The fluorescence data were collected during the annealing step of 55°C and 58°C, respectively, in all runs.

2.4. Conventional one‐step RT‐PCR {#irv12407-sec-0011}
---------------------------------

Superscript III One‐Step RT‐PCR kit with Platinum Taq polymerase (Invitrogen ^TM^ GmbH, Karlsruhe, Germany) was used for conventional RT‐PCR. Thermocycling conditions on an Analytik Jena Flex Cycler or a SensoQuest Labcycler were optimized by adapting annealing time and temperature. These cycling conditions were found to be optimal for the generic pan‐HA and pan‐NA [32](#irv12407-bib-0032){ref-type="ref"}, [33](#irv12407-bib-0033){ref-type="ref"} RT‐PCRs:

30 minutes 50°C, 2 minutes 94°C, 45 cycles each of 30 seconds 94°C -- 45 seconds 50°C -- 45 seconds 68°C, final elongation 5 minutes 68°C.

The cycling conditions for an optimized version of the generic pan‐HA‐SIV RT‐PCR were found to be optimal at:

30 minutes 48°C, 2 minutes 94°C, 45 cycles each of 30 seconds 94°C -- 30 seconds 55°C -- 40 seconds 68°C, final elongation 2 minutes 68°C.

2.5. Sequencing {#irv12407-sec-0012}
---------------

The subtype and lineage of SIV isolates and PCR‐positive field samples were determined by Sanger sequencing of RT‐PCR‐amplified fragments of the HA and NA gene segments using the pan‐HA and pan‐NA conventional RT‐PCRs described by Gall et al.[32](#irv12407-bib-0032){ref-type="ref"}, [33](#irv12407-bib-0033){ref-type="ref"} (2008, 2009) and further modified in this study. These PCRs generate an HA fragment of approximately 180 bp spanning the HA cleavage site and a 630‐bp fragment of the 5′ region of the NA gene segment. For selected SIV isolates, full‐length HA and NA sequences were obtained using RT‐PCRs described by Starick et al.[34](#irv12407-bib-0034){ref-type="ref"} (2011). Specific amplicons were purified from 1.5% agarose gels using a QIAquick gel extraction kit (Qiagen, Hilden, Germany) and Sanger‐sequenced using the RT‐PCR primers. The sequences were analysed on an ABI 310 sequencer, curated using the Chromas Lite^®^ software (<http://www.technelysium.com.au/Chromas250Setup.exe>) and assembled using the CAP3 programme (<http://doua.prabi.fr/software/cap3>).

2.6. Molecular sequence analyses {#irv12407-sec-0013}
--------------------------------

The IRD or GISAID databases were screened with BLASTN2 to identify closely related sequences of the pan‐HA and pan‐NA sequences.

3. Results {#irv12407-sec-0014}
==========

3.1. Assembly and analytical performance of subtype‐specific uniplex RT‐qPCRs for the detection and differentiation of HA and NA lineages of European SIV {#irv12407-sec-0015}
---------------------------------------------------------------------------------------------------------------------------------------------------------

Significant sequence variation exists within and between the HA and NA subtypes and lineages of SIV from Europe. Sequence stretches conserved within one lineage, yet distinctively different from other lineages were found to be rare even if only the 3′ termini of potential primers and/or the central region of probes were considered. Extensive in silico analysis showed that degeneration of primers at up to four positions or the use of more than two primers per PCR was inevitable to span the whole width of (published) sequence variation within a single lineage (Table [1](#irv12407-tbl-0001){ref-type="table-wrap"}). Primers selected by this strategy for the human‐derived H1huN2 lineage gave rise to false (cross‐subtype‐) priming and resulted in non‐specific amplification (data not shown). In an attempt to design more specific primers, dual priming oligonucleotides (DPO) were developed. Dual priming oligonucleotides primers are composed of a longer 5′ sequence stretch which serves as an anchor to firmly position the primer at the target site, and degenerate nucleotides can be included into this anchor region. The shorter 3′ region of the DPO primer of usually less than 12 nucleotides enforces highly specific hybridization within a fully matching target sequence. The two regions are separated by a stretch of five inosine residues.[30](#irv12407-bib-0030){ref-type="ref"}, [38](#irv12407-bib-0038){ref-type="ref"}

RNA obtained from a panel of 20 IAV of subtype H1, H3, N1 and N2 of human, avian or porcine origin was used to evaluate different sets of primers and probes for their analytical specificity for different lineages of European SIV. Results shown in Table [2](#irv12407-tbl-0002){ref-type="table-wrap"}A prove that the sets finally chosen discriminated between the HA H1 lineages: (i) pandemic H1 (H1pdm), (ii) endemic avian‐origin porcine H1 (H1av) and (iii) H1 of the human‐derived H1N2 subtype (H1hu) and subtype porcine H3 (H3). The H1hu RT‐qPCR also detected the HA of pre‐2009 seasonal human H1N1 lineage represented by a historic (A/FM/1/1947) and a more recent human isolate (A/Germany‐NDS/14/2007). This (cross‐) reactivity is expected as the porcine H1hu lineage is derived as a reassortant from human seasonal H1N1 from the 1990s. No cross‐reactivity was observed with recent H1 and H3 IAV of avian origin.

###### 

Analytical specificity of primers and probes for detection and differentiation of HA (A) and NA (B) lineages of swine influenza viruses from Europe. Results are based on uniplex RT‐qPCRs

  \(A\) RT‐qPCRs targeting the haemagglutinin gene (isolates sorted by HA subtype/lineage)                                               
  ------------------------------------------------------------------------------------------ ------- ------- ------ ------ ------ ------ ------
  A/Germany/Regensburg/2009                                                                  H1pdm   N1pdm   23.6   22.5   neg.   neg.   neg.
  A/Germany/NJH‐R26/2011                                                                     H1pdm   N1pdm   20.8   21.2   neg.   neg.   neg.
  A/Swine/Germany/R75/2011                                                                   H1pdm   N2      18.3   17.9   neg.   neg.   neg.
  A/Swine/Germany/R708/2010                                                                  H1pdm   N1av    22.2   19.6   neg.   neg.   neg.
  A/Swine/Belzig/2/2001                                                                      H1av    N1av    18.7   neg.   17.6   neg.   neg.
  A/Swine/Germany/R819/2010                                                                  H1av    N1av    21.9   neg.   25.0   neg.   neg.
  A/Swine/Germany/R248/2010                                                                  H1av    N1av    23.9   neg.   22.5   neg.   neg.
  A/Swine/Germany/R1738/2010                                                                 H1av    N1av    21.0   neg.   17.6   neg.   neg.
  A/Swine/Germany/R369/2009                                                                  H1av    N2      23.6   neg.   24.3   neg.   neg.
  A/Swine/Bakum/1893/2000                                                                    H1hu    N2      21.9   neg.   neg.   22.3   neg.
  A/Swine/Germany/R757/2010                                                                  H1hu    N2      18.6   neg.   neg.   21.1   neg.
  A/Swine/Germany‐NI/R3394/2009                                                              H1hu    N1av    21.2   neg.   neg.   21.3   neg.
  A/Fort Monmoth/1/1947                                                                      H1      N1      24.2   neg.   neg.   23.5   neg
  A/Germany‐NDS/14/2007                                                                      H1      N1      29.0   neg.   neg.   32.9   neg.
  A/White‐fronted goose/Germany/R482/2009                                                    H1      N1      21.6   neg.   neg.   neg.   neg.
  A/Wild duck/Germany/R30/2006                                                               H1      N1      24.9   neg.   neg.   neg.   neg.
  A/Swine/Bakum/909/1993                                                                     H3      N2      23.2   neg.   neg.   neg.   22.2
  A/Swine/Germany/R96/2011                                                                   H3      N2      18.5   neg.   neg.   neg.   19.2
  A/Swine/Germany/R76/2011                                                                   H3      N2      21.8   neg.   neg.   neg.   22.1
  A/Waterfowl/Germany/2311/2009                                                              H3      N8      24.7   neg.   neg.   neg.   neg.
  A/Germany‐BW/23/2007                                                                       B       B       neg.   neg.   neg.   neg.   neg.
  Tetraplex mixture                                                                                                 FAM    HEX    ROX    CY5

  \(B\) RT‐qPCRs targeting the neuraminidase gene (isolates sorted by NA subtype/lineage)                                        
  ----------------------------------------------------------------------------------------- ------- ------- ------ ------ ------ ------
  A/Swine/Belzig/2/2001                                                                     H1av    N1av    14.5   16.3   neg.   neg.
  A/Swine/Germany‐NI/R3394/2009                                                             H1hu    N1av    15.3   14.6   neg.   neg.
  A/Swine/DE/R708/2010                                                                      H1pdm   N1av    19.0   17.2   neg.   neg.
  A/Swine/DE/R819/2010                                                                      H1av    N1av    16.3   16.5   neg.   neg.
  A/Swine/DE/R248/2010                                                                      H1av    N1av    19.5   19.7   neg.   neg.
  A/Swine/DE/R1738/2010                                                                     H1av    N1av    17.2   17.6   neg.   neg.
  A/White‐fronted goose/Germany/R482/2009                                                   H1      N1      18.0   19.9   neg.   neg.
  A/Wild duck/Germany/R30/2006                                                              H1      N1      16.2   17.6   neg.   neg.
  A/Fort Monmoth/1/1947                                                                     H1      N1      15.1   15.3   neg.   neg.
  A/Germany‐NDS/14/2007                                                                     H1      N1      20.6   19.0   neg.   neg.
  A/Germany/Regensburg/2009                                                                 H1pdm   N1pdm   18.7   20.0   20.0   neg.
  A/Germany/NJH‐R26/2011                                                                    H1pdm   N1pdm   17.9   18.2   19.1   neg.
  A/Swine/Bakum/1893/2000                                                                   H1hu    N2      16.5   neg.   neg.   23.3
  A/Swine/Germany/R757/2010                                                                 H1hu    N2      15.0   neg.   neg.   17.0
  A/Swine/Germany/R75/2011                                                                  H1pdm   N2      13.7   neg.   neg.   19.1
  A/Swine/Germany/R369/2009                                                                 H1av    N2      18.8   neg.   neg.   18.3
  A/Swine/Bakum/909/1993                                                                    H3      N2      18.8   neg.   neg.   19.5
  A/Swine/Germany/R96/2011                                                                  H3      N2      15.0   neg.   neg.   15.2
  A/Swine/Germany/R76/2011                                                                  H3      N2      18.1   neg.   neg.   19.3
  A/Waterfowl/Germany/2311/2009                                                             H3      N8      neg.   neg.   neg.   neg.
  A/Germany‐BW/23/2007                                                                      B       B       neg.   neg.   neg.   neg.
  Triplex mixture                                                                                                  FAM    ROX    HEX

neg.: Negative.
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In contrast to HA‐specific PCRs, no host‐specific differentiation of N1 and N2 subtypes was attempted. Instead, broadly reacting RT‐qPCRs for subtypes N1 (N1all) and N2 were established (Hoffmann et al.; FLI, Greifswald‐Insel Riems, Germany, submitted for publication) and tested favourably with the reference RNA panel (Table [2](#irv12407-tbl-0002){ref-type="table-wrap"}B). In addition, another RT‐qPCR specifically detecting the N1 of the human pandemic/2009 H1N1 lineage (N1pdm) was developed. Thus, N1pdm‐positive viruses gave positive results with both the N1all and the N1pdm RT‐qPCRs (Table [2](#irv12407-tbl-0002){ref-type="table-wrap"}B).

None of the primer and probe sets gave false‐positive results when tested with IAV subtypes H1 and H3 of avian origin (Table [2](#irv12407-tbl-0002){ref-type="table-wrap"}).

Non‐specific reactivity of these PCRs with other porcine viral or bacterial respiratory pathogens as listed in Table S1 was excluded.

3.2. Assembly and analytical performance of tetraplex (4plex) and triplex (3plex) RT‐qPCRs for the detection of haemagglutinin and neuraminidase sequences of European SIV {#irv12407-sec-0016}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The HA‐ and NA‐specific probes were labelled with different colours: FAM---H1pdm, HEX---H1av, ROX---H1hu, Cy5---H3; FAM---N1, ROX---N1pdm, HEX---N2. Primers and probes for each of the four HA and for the three NA targets were mixed generating a tetra‐ and a triplex amplification assay, respectively. Series of 10‐fold diluted RNA of eight representative virus isolates (two for each porcine HA subtype/lineage) were used to check for possible impact on the RT‐qPCR performance that may result from mixing the sets of primer and probes. No impairment of performance was noticed. Thus, detection continued to be highly lineage‐ and/or subtype‐specific and no cross‐reaction was evident even in samples with very high virus loads (data not shown). Comparison of Cq values of serial 10‐fold RNA dilutions with results of the generic M‐specific RT‐qPCR was used to assess the relative analytical sensitivity of the multiplex RT‐qPCRs. In general, relative detection limits of the multiplex RT‐qPCRs were slightly lower (up to 3 Cq values) than those of the corresponding M RT‐qPCR (Table [3](#irv12407-tbl-0003){ref-type="table-wrap"}).

###### 

Relative sensitivity of tetraplex HA‐ and triplex NA‐specific RT‐qPCRs compared with IAV‐generic M‐specific amplification

  \(A\)                                                    
  ------- ------ ------ ------ ------ ------ ------ ------ ------
  0       24.3   22.3   24.5   23.1   22.5   22.9   22.6   21.3
  −1      27.2   25.3   26.1   26.6   25.6   26.4   26.1   24.7
  −2      30.5   28.9   29.4   30.1   29.1   30.4   29.2   28.4
  −3      34.2   33.3   32.8   34.7   32.1   33.8   32.5   33.0
  −4      36.6   39.8   35.4   neg.   35.4   neg.   36.1   neg.
  −5      neg.   neg.   neg.   neg.   neg.   neg.   neg.   neg.
  −6      neg.   neg.   neg.   neg.   neg.   neg.   neg.   neg.

  **(B)**                                      
  --------- ------ ------ ------ ------ ------ ------
  0         24.5   24.8   24.3   26.0   24.3   25.2
  −1        26.1   28.4   27.2   30.0   27.5   28.4
  −2        29.4   31.8   30.5   33.6   31.0   32.0
  −3        32.8   35.4   34.2   37.2   33.8   34.6
  −4        35.4   39.1   36.6   39.7   37.8   38.6
  −5        neg.   neg.   neg.   neg.   neg.   neg.
  −6        neg.   neg.   neg.   neg.   neg.   neg.

neg.: Negative.

Serial 10‐fold dilutions of SIV RNA were examined by M‐ and tetraplex HA‐ (A) and triplex NA‐specific (B) RT‐qPCRs.

H1pdm, N1pdm---A/Germany‐MV/R26/2011; H1av N1av---A/Swine/Germany/AR1738/2010; H1huN2---A/Swine/Germany/AR1141/2014; H3N2---A/Swine/Germany/R655/2012.
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3.3. Detection of SIV double infections by HA‐specific tetraplex and NA‐specific triplex RT‐qPCRs {#irv12407-sec-0017}
-------------------------------------------------------------------------------------------------

Infection of the same cell by more than one IAV geno‐ or subtype is the prerequisite of reassortment. The possibility to detect influenza virus co‐infections in the same clinical samples is of interest in surveillance programmes. In order to mimic double infections, RNA of viruses of four different porcine HA and three NA subtypes/lineages, respectively, was mixed to represent all possible combinations (Table [4](#irv12407-tbl-0004){ref-type="table-wrap"}). The RNA of two viruses was mixed in approximately equal amounts, in 95:5 and in 5:95 to mimic an up to 20‐fold difference in RNA content (Table [4](#irv12407-tbl-0004){ref-type="table-wrap"}). Cq values of the M‐specific RT‐qPCR were used to normalize the concentration of viral RNA, assuming that this PCR‐amplified viral RNA of the different lineages with similar efficacy. In all cases, both HA and NA (if disparate) targets present in the sample were detected and discerned in all mixtures. Again, no cross‐reactivity to lineages not represented in the sample mix was evident.

###### 

Detection of mixtures of different European SIV HA and NA lineages by tetraplex HA‐ (A) and triplex NA‐specific (B) RT‐qPCRs

  \(A\)                                     
  ------------ ------- ------ ------ ------ ------
  H1pdm/H1av   95/5    26.1   35.8   neg.   neg.
  H1pdm/H1av   50/50   27.1   28.8   neg.   neg.
  H1pdm/H1av   5/95    31.0   27.6   neg.   neg.
  H1pdm/H3     95/5    25.9   neg.   neg.   32.3
  H1pdm/H3     50/50   27.0   neg.   neg.   25.2
  H1pdm/H3     5/95    31.2   neg.   neg.   24.1
  H1pdm/H1hu   95/5    26.0   neg.   30.4   neg.
  H1pdm/H1hu   50/50   27.0   neg.   25.4   neg.
  H1pdm/H1hu   5/95    31.5   neg.   24.6   neg.
  H1hu/H3      95/5    neg.   neg.   24.7   30.8
  H1hu/H3      50/50   neg.   neg.   25.5   25.6
  H1hu/H3      5/95    neg.   neg    30.6   24.3
  H1hu/H1av    95/5    neg.   27.7   27.7   neg.
  H1hu/H1av    50/50   neg.   28.7   25.6   neg.
  H1hu/H1av    5/95    neg.   33.3   24.4   neg.
  H1av/H3      95/5    neg.   26.9   neg.   30.5
  H1av/H3      50/50   neg.   28.2   neg.   25.5
  H1av/H3      5/95    neg.   33.3   neg.   24.1

  \(B\)                                 
  --------------- ------- ------ ------ ------
  N1pdm/N1av      95/5    26.3   26.6   neg.
  N1pdm/N1av      50/50   26.4   27.7   neg.
  N1pdm/N1av      5/95    26.5   31.3   neg.
  N1pdm/N2 (H3)   95/5    26.5   26.2   29.3
  N1pdm/N2 (H3)   50/50   27.5   27.6   26.7
  N1pdm/N2 (H3)   5/95    30.6   31.6   26.2
  N1av/N2 (H3)    95/5    26.0   neg.   29.5
  N1av/N2 (H3)    50/50   27.0   neg.   26.9
  N1av/N2 (H3)    5/95    29.8   neg.   25.8

neg.: Negative.

For tetraplex HA RT‐qPCR mixtures, RNA extracted from the following SIV isolates was mixed: H1N1pdm---A/Swine/Germany/1760/2014; H1N1av---A/Swine/Germany/AR1738/2010; H1huN2---A/Swine/Germany/AR1146/2014; H3N2---A/Swine/Germany/R655/2012.

Triplex NA RT‐qPCR mixtures consisted of RNA extracted from the following SIV isolates: H1N1pdm---A/Swine/Germany/1759/2014; H1N1av---A/Swine/Germany/AR1696/2014; H3N2---A/Swine/Germany/R655/2012.

The relative amount of RNA was normalized to a dilution that generated a Cq value of 25‐26 using the M‐specific RT‐qPCR for all isolates. Then, the mixtures were prepared to yield the percentage values indicated in the second column of the tables.
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3.4. Diagnostic performance of the HA‐specific tetraplex‐ and NA‐specific triplex RT‐qPCRs {#irv12407-sec-0018}
------------------------------------------------------------------------------------------

A total of 27 SIV isolates obtained in MDCK cell cultures and 27 porcine nasal swabs which had tested positive for IAV RNA by M‐specific RT‐qPCR were derived from European swine populations with overt respiratory symptoms. In addition, 27 porcine nasal swab samples that tested negative for IAV RNA were examined. The multiplex RT‐qPCRs did not yield positive signals for any of the IAV‐negative samples (data not shown). Subtyping results obtained by the newly developed multiplex RT‐qPCRs for M‐positive isolates and samples were compared to those generated by conventional RT‐PCR and amplicon Sanger sequencing. For this purpose, pan‐HA and pan‐NA RT‐PCRs were used as published by Gall et al.[32](#irv12407-bib-0032){ref-type="ref"}, [33](#irv12407-bib-0033){ref-type="ref"} (2008, 2009).

Tables [5](#irv12407-tbl-0005){ref-type="table-wrap"}A/B compares subtyping results by HA and NA amplicon sequencing and by HA and NA multiplex RT‐qPCRs for clinical SIV isolates. Test of all RNAs extracted from isolates indicated high virus loads as indicated by the M‐specific Cq values (range 16--23). All the HA and NA subtypes were unambiguously assignable by multiplex RT‐qPCRs with the exception of three isolates for which no signal was obtained in the HA tetraplex RT‐qPCR (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}A). Full‐length sequences of genome segment 4 encoding the HA protein were generated from these three isolates and the sequences compared to the oligonucleotide sequence of the primers and probe used in the subtyping RT‐qPCRs. This analysis revealed a considerable number of mismatches (Fig. S1a). Also, the products of the tetraplex RT‐qPCR of these isolates were examined by gel electrophoresis (Fig. S1b), but no specific amplicons were detected. In two cases (AR1123/15 and 2196/15, Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}A), the multiplex RT‐qPCRs detected the presence of a mixture of H1av and H1hu subtypes in the same isolate.

###### 

Haemagglutinin and neuraminidase subtyping of RNA of European SIV extracted from isolates (A, B) or from clinical samples (C, D) by multiplex RT‐qPCR (this study) or conventional multiplex RT‐PCR and Sanger sequencing

  \(A\) SIV isolates, HA                                                                                         
  ------------------------ ---- -------------- ------ ------ ------ ------ ------ ------- -------------- ------- ---------
  AR 1279/15               ES   H1avN1av       16.8   neg.   34.4   neg.   neg.           H1av                   H1av
  AR 1340/15               FR   H1avN1av       22.8   neg.   23.1   neg.   neg.           H1av                   H1av
  AR 1348/15               FR   H1avN1av       16.0   neg.   19.1   neg.   neg.           H1av                   H1av
  AR 2618/15               BE   H1avN1av       16.1   neg.   23.6   neg.   neg.           Questionable   H1av    H1av
  AR 2754/15               FR   H1avN1av       18.6   neg.   18.4   neg.   neg.           Failed         H1av    H1av
  AR 2778/15               FR   H1avN1av       17.3   neg.   19.1   neg.   neg.           Failed         H1av    H1av
  AR 2783/15               FR   H1avN1av       18.6   neg.   20.1   neg.   neg.           H1av                   H1av
  AR 2667/15               DK   **H1avN2**     27.7   neg.   19.0   neg.   neg.           Questionable   H1av    H1av
  AR 2759/15               UK   **H1avN2**     23.3   neg.   neg.   neg.   neg.           Failed         H1av    H1av
  AR 3067/15               DK   **H1avN2**     14.7   neg.   17.2   neg.   neg.           Questionable   H1av    H1av
  AR 1123/15               FR   **H1av/hu**    20.6   neg.   22.3   22.3   neg.           H1av/hu                H1av/hu
  AR 2196/15               FR   **H1av/hu**    18.2   neg.   20.0   26.3   neg.           Failed         H1av    H1av/hu
  AR 1359/15               FR   H1huN2         18.0   neg.   neg.   neg.   neg.           H1hu                   H1hu
  AR 1372/15               ES   H1huN2         16.2   neg.   neg.   22.1   neg.           H1hu                   H1hu
  AR 2023/15               FR   H1huN2         19.0   neg.   neg.   30.6   neg.           H1hu                   H1hu
  AR 2829/15               DE   H1huN2         16.3   neg.   neg.   26.2   neg.   H1hu                           H1hu
  AR 647/15                NL   **H1huN1av**   18.7   neg.   neg.   20.5   neg.           H1hu                   H1hu
  AR 2056/15               NL   **H1huN1av**   19.1   neg.   neg.   20.2   neg.           H1hu                   H1hu
  AR 2082/15               NL   **H1huN1av**   19.7   neg.   neg.   20.5   neg.           H1hu                   H1hu
  AR 1855/15               DK   H1pdmN1pdm     17.9   18.9   neg.   neg.   neg.   H1pdm                          H1pdm
  AR 2675/15               FR   H1pdmN1pdm     18.3   21.1   neg.   neg.   neg.           Questionable   H1pdm   H1pdm
  AR 2749/15               DE   **H1pdmN2**    17.4   19.9   neg.   neg.   neg.   H1pdm                          H1pdm
  AR 531/15                NL   H3N2           19.6   neg.   neg.   neg.   18.1           Questionable   H3      H3
  AR 543/15                NL   H3N2           20.2   neg.   neg.   neg.   17.6           H3                     H3
  AR 1203/15               BE   H3N2           22.6   neg.   neg.   neg.   20.2           H3                     H3
  AR 1204/15               BE   H3N2           19.1   neg.   neg.   neg.   18.1           H3                     H3
  AR 3179/15               NL   H3N2           13.2   neg.   neg.   neg.   neg.           H3                     H3

  \(B\) SIV isolates, NA                                                                    
  ------------------------ ---- -------------- ------ ------ ------ ------ ------- -------- -------
  AR 1279/15               ES   H1avN1av       16.8   26.1   neg.   neg.           N1       N1av
  AR 1340/15               FR   H1avN1av       22.8   22.8   neg.   neg.           N1       N1av
  AR 1348/15               FR   H1avN1av       16.0   17.9   neg.   neg.           N1       N1av
  AR 2618/15               BE   H1avN1av       16.1   16.4   neg.   neg.           N1       N1av
  AR 2754/15               FR   H1avN1av       18.6   17.4   neg.   neg.           N1       N1av
  AR 2778/15               FR   H1avN1av       17.3   19.7   neg.   neg.           N1       N1av
  AR 2783/15               FR   H1avN1av       18.6   21.2   neg.   neg.           N1       N1av
  AR 2667/15               DK   **H1avN2**     27.7   neg.   neg.   19.4           N2       N2
  AR 2759/15               UK   **H1avN2**     23.3   neg.   neg.   25.3           N2       N2
  AR 3067/15               DK   **H1avN2**     14.7   neg.   neg.   19.4           N2       N2
  AR 1123/15               FR   **H1av/hu**    20.6   20.1   neg.   neg.           N1       N1av
  AR 2196/15               FR   **H1av/hu**    18.2   17.7   neg.   neg.           N1       N1av
  AR 1359/15               FR   H1huN2         18.0   neg.   neg.   18.4           Failed   N2
  AR 1372/15               ES   H1huN2         16.2   neg.   neg.   17.6           N2       N2
  AR 2023/15               FR   H1huN2         19.0   neg.   neg.   31.1           N2       N2
  AR 2829/15               DE   H1huN2         16.3   neg.   neg.   17.6   N2               N2
  AR 647/15                NL   **H1huN1av**   18.7   17.9   neg.   neg.           N1       N1av
  AR 2056/15               NL   **H1huN1av**   19.1   18.7   neg.   neg.           N1       N1av
  AR 2082/15               NL   **H1huN1av**   19.7   18.5   neg.   neg.           N1       N1av
  AR 1855/15               DK   H1pdmN1pdm     17.9   20.5   18.4   neg.   N1pdm            N1pdm
  AR 2675/15               FR   H1pdmN1pdm     18.3   19.9   19.1   neg.           N1pdm    N1pdm
  AR 2749/15               DE   **H1pdmN2**    17.4   neg.   neg.   21.1   N2               N2
  AR 531/15                NL   H3N2           19.6   neg.   neg.   25.3           N2       N2
  AR 543/15                NL   H3N2           20.2   neg.   neg.   32.2           N2       N2
  AR 1203/15               BE   H3N2           22.6   neg.   neg.   28.9           N2       N2
  AR 1204/15               BE   H3N2           19.8   neg.   neg.   25.4           N2       N2
  AR 3179/15               NL   H3N2           13.2   neg.   neg.   13.9           N2       N2

  \(C\) Clinical samples, HA                                                                              
  ---------------------------- ---- ---------------- ------ ------ ------ ------ ------ -------- -------- -----------
  AR 849/15                    FR   **H1avN1av**     22.0   neg.   27.2   neg.   neg.   Failed   H1av     **H1av**
  AR 1350/15                   FR   **H1avN1av**     29.9   neg.   32.5   neg.   neg.   Failed   H1av     **H1av**
  AR 1520/15                   FR   **H1avN1av**     25.8   neg.   22.5   neg.   neg.   H1av              **H1av**
  AR 1766/15                   DE   **H1avN1av**     20.1   neg.   21.0   neg.   neg.   H1av              **H1av**
  AR 2089/15                   NL   **H1avN1av**     35.0   neg.   25.8   neg.   neg.   Failed   Failed   **H1av**
  AR 2297/15                   FR   **H1avN1av**     29.2   neg.   32.9   neg.   neg.   Failed   Failed   **H1av**
  AR 2435/15                   ES   **H1avN1av**     32.3   neg.   32.2   neg.   neg.   Failed   Failed   **H1av**
  AR 3298/15                   FR   **H1avN1av**     27.7   neg.   28.2   neg.   neg.   Failed   H1av     **H1av**
  AR 682/15                    ES   H1avN2           26.5   neg.   29.5   neg.   neg.   Failed   H1av     H1av
  AR 856/15                    ES   H1avN2           28.5   neg.   31.5   neg.   neg.   Failed   H1av     H1av
  AR 1051/15                   ES   H1avN2           30.6   neg.   38.3   neg.   neg.   Failed   Failed   H1av
  AR 1992/15                   DK   H1avN2           34.8   neg.   35.0   neg.   neg.   Failed   Failed   H1av
  AR 1996/15                   DK   H1avN2           26.8   neg.   24.3   neg.   neg.   Failed   H1av     H1av
  AR 2662/15                   DK   H1avN2           34.5   neg.   25.9   neg.   neg.   Failed   H1av     H1av
  AR 2975/15                   DK   H1avN2           24.6   neg.   28.5   neg.   neg.   Failed   Failed   H1av
  AR 482/15                    NL   **H1huN2**       24.4   neg.   neg.   28.9   neg.   Failed   H1hu     **H1hu**
  AR 1355/15                   FR   **H1huN2**       26.8   neg.   neg.   30.3   neg.   Failed   H1hu     **H1hu**
  AR 3002/15                   BE   **H1huN2**       22.9   neg.   neg.   26.2   neg.   Failed   H1hu     **H1hu**
  AR 3437/15                   NL   **H1huN2**       25.9   neg.   neg.   27.9   neg.   Failed   H1hu     **H1hu**
  AR 2061/15                   NL   H1huN1av         26.5   neg.   neg.   21.2   neg.   H1hu              H1hu
  AR 1843/15                   DK   **H1pdmN1pdm**   25.3   25.2   neg.   neg.   neg.   Failed   H1pdm    **H1pdm**
  AR 2652/15                   DK   **H1pdmN1pdm**   24.9   24.7   neg.   neg.   neg    Failed   H1pdm    **H1pdm**
  AR 3404/15                   FR   **H1pdmN1pdm**   29.0   27.4   neg.   neg.   neg.   Failed   H1pdm    **H1pdm**
  AR 112/16                    FR   **H1pdmN1pdm**   25.3   24.1   neg.   neg.   neg.   Failed   H1pdm    **H1pdm**
  AR 2906/15                   UK   H1pdmN1av        34.7   35.6   neg.   neg    neg.   Failed   Failed   H1pdm
  AR 544/15                    NL   **H3N2**         26.0   neg.   neg.   neg.   34.2   Failed   H3       **H3**
  AR 220/16                    NL   **H3N2**         22.3   neg    neg.   neg.   24.3   H3                **H3**

  \(D\) Clinical samples, NA                                                              
  ---------------------------- ---- ---------------- ------ ------ ------ ------ -------- -----------
  AR 849/15                    FR   **H1avN1av**     22.0   22.1   neg.   neg.   N1       **N1av**
  AR 1350/15                   FR   **H1avN1av**     29.9   29.4   neg.   neg.   N1       **N1av**
  AR 1520/15                   FR   **H1avN1av**     25.8   24.6   neg.   neg.   N1       **N1av**
  AR 1766/15                   DE   **H1avN1av**     20.1   19.3   neg.   neg.   N1       **N1av**
  AR 2089/15                   NL   **H1avN1av**     35.0   32.6   neg.   neg.   Failed   **N1av**
  AR 2297/15                   FR   **H1avN1av**     29.2   29.0   neg.   neg.   N1       **N1av**
  AR 2435/15                   ES   **H1avN1av**     32.3   30.6   neg.   neg.   Failed   **N1av**
  AR 3298/15                   FR   **H1avN1av**     27.7   26.9   neg.   neg.   N1       **N1av**
  AR 682/15                    ES   H1avN2           26.5   neg.   neg.   30.6   N2       N2
  AR 856/15                    ES   H1avN2           28.5   neg.   neg.   31.7   N2       N2
  AR 1051/15                   ES   H1avN2           30.6   neg.   neg.   32.1   Failed   N2
  AR 1992/15                   DK   H1avN2           34.8   neg.   neg.   35.6   Failed   N2
  AR 1996/15                   DK   H1avN2           26.8   neg.   neg.   25.4   Failed   N2
  AR 2662/15                   DK   H1avN2           34.5   neg.   neg.   27.9   N2       N2
  AR 2975/15                   DK   H1avN2           24.6   neg.   neg.   26.0   N2       N2
  AR 482/15                    NL   **H1huN2**       24.4   neg.   neg.   27.4   N2       **N2**
  AR 1355/15                   FR   **H1huN2**       26.8   neg.   neg.   28.1   N2       **N2**
  AR 3002/15                   BE   **H1huN2**       22.9   neg.   neg.   23.2   N2       **N2**
  AR 3437/15                   NL   **H1huN2**       25.9   neg.   neg.   25.9   N2       **N2**
  AR 2061/15                   NL   H1huN1av         26.5   23.6   neg.   neg.   N1       N1av
  AR 1843/15                   DK   **H1pdmN1pdm**   25.3   26.2   25.4   neg.   N1pdm    **N1pdm**
  AR 2652/15                   DK   **H1pdmN1pdm**   24.9   23.3   22.2   neg.   N1pdm    **N1pdm**
  AR 3404/15                   FR   **H1pdmN1pdm**   29.0   28.5   26.8   neg.   N1pdm    **N1pdm**
  AR 112/16                    FR   **H1pdmN1pdm**   25.3   26.1   23.4   neg.   N1pdm    **N1pdm**
  AR 2906/15                   UK   H1pdmN1av        34.7   34.8   neg.   neg.   Failed   N1av
  AR 544/15                    NL   **H3N2**         26.0   neg.   neg.   31.5   N2       **N2**
  AR 220/16                    NL   **H3N2**         22.3   neg.   neg.   21.9   N2       **N2**

neg.: Negative.

"Sample number" indicates the identity of a sample (AR NNNN) and the year of sampling (/YR).

Bold‐face subtype signal HA/NA reassortants.

"failed" and "questionable" indicate that a no or only very short nucleotide sequences were generated.

"Harmonized results" identifies the subtype pattern as defined by combined results from RT‐qPCRs and RT‐PCR/sequencing.
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Haemagglutinin and NA subtypes could be assigned to all of the clinical samples when tested by the multiplex RT‐qPCRs (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}C/D); however, this sample type revealed a greater variation in viral loads (range 21--35) compared with the cell‐grown isolates.

Amplicon sequencing based on the pan‐HA/pan‐NA RT‐PCRs described by Gall et al.[32](#irv12407-bib-0032){ref-type="ref"}, [33](#irv12407-bib-0033){ref-type="ref"}2008/2009 was used to verify subtyping results generated by multiplex RT‐qPCRs. However, 9 of 27 isolates and 23 of 27 clinical samples failed to yield reliable HA sequences (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}, "questionable") or failed to produce any amplicons at all (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}, "failed"). The NA subtyping was affected at a much lower rate (one isolate and six clinical samples failed). These results prompted us to establish updated primers of the pan‐HA PCR that provided a better match with European SIV and yielded enhanced amplification sensitivity. Modified primers are listed in Table [1](#irv12407-tbl-0001){ref-type="table-wrap"}B. Using the updated pan‐HA primer set in a multiplex RT‐PCR (termed "pan‐HA‐SIV"), it was possible to sequence amplicons for all 9 isolates which had failed before, and for 16 of the 23 failed clinical samples (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}).

Finally, a harmonized diagnosis was made by combining the results of the multiplex RT‐qPCR and the RT‐PCR/amplicon sequencing: in all cases for which results for both methods were available, fully matching subtyping results were obtained for both HA and NA (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}A--D). For seven HA samples for which also the updated primer set failed to produce an amplicon and for one failed NA sample, multiplex RT‐qPCRs were able to assign a subtype.

4. Discussion {#irv12407-sec-0019}
=============

Despite the fact that zoonotic and even pandemic potential in SIV has been noticed repeatedly, no sustained government‐administrated surveillance programmes currently operate in Europe, with the sole exception of France, that target SIV in swine populations.[18](#irv12407-bib-0018){ref-type="ref"} Technical problems and high costs associated with previously established SIV detection and subtyping tools may at least in part be related to the diffidence of embarking on monitoring on a larger scale. This discrepancy was taken as an incentive to develop more productive SIV subtyping tools.

Real‐time PCR is an established method in most routine diagnostic laboratories. The use of multiplex assays allows time‐efficient and cost‐effective examination of several parameters in the same tube.[40](#irv12407-bib-0040){ref-type="ref"} The ultimate goal of this study was to distinguish HA and NA lineages of SIV circulating in Europe and was achieved by the establishment of two multiplex RT‐qPCRs. Selection of primers and probes proved to be difficult as sequence stretches that are broadly conserved within one lineage (inclusivity) but distinct to all other ones (exclusivity) are scarce, especially in the HA genome segment. Therefore, primers and probes had to be constructed with a number of degenerate positions. In addition, mixtures of up to four primers for the same target had to be used. Finally, for the distinction of the human‐derived HA H1 lineage of SIV (H1hu), a double‐priming strategy had to be implemented. Validation of the analytical specificity of primers and probes in the uni‐ and multiplex formats confirmed their lineage‐specific reactivity, and therefore, detection of double infections with different lineages in the same sample was possible with high reliability. Significant advantages of the multiplex RT‐qPCRs over the original amplicon sequencing system were evident, especially for direct subtyping from clinical samples. Even samples with marginal RNA contents (Cq values up to 35) could be subtyped by RT‐qPCRs but failed to react even in the updated amplicon sequencing system, pan‐HA‐SIV.

When analysing RNA from SIV isolates, limits of the inclusivity of the multiplex RT‐qPCR became evident: despite the presence of high RNA loads in the samples (as evidenced by M RT‐qPCR), one isolate each of the H1av, H1hu and H3 lineage was not detected by the tetraplex HA‐specific RT‐qPCR; however, amplicon sequencing succeeded in all three cases to identify the HA subtype. Full‐length sequencing of the HA open reading frame of these isolates revealed a substantial number of mutated positions affecting the binding of both primers and probes (Table [6](#irv12407-tbl-0006){ref-type="table-wrap"}) which likely prevented amplification (Figs S1 and S2). A constant control and timely adaptation of oligonucleotides in the multiplex RT‐qPCRs is essential.

###### 

Mismatches of primers and probes for the three SIV isolates which remained negative in the tetraplex HA RT‐qPCR (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}A)

  Isolate identification   Primer   Mismatches                  
  ------------------------ -------- ------------ -------------- ---
  AR 2759/15               UK       H1avN2       H1av_Sw_Fn     2
  H1av_Sw_R1               8                                    
  H1av_Sw_R2               7                                    
  H1av_Sw_HEX_1            4                                    
  AR 1359/15               FR       H1huN2       H1hu_Sw_F\_2   1
  H1\[N2\]\_Swine_Fw       2                                    
  H1hu_Sw_R\_2             3                                    
  H1\[N2\]\_Swine_Rv       1                                    
  H1hu_Sw_ROX              2                                    
  AR 3179/15               NL       H3N2         H3_Sw_F2       2
  H3_Sw_R2                 2                                    
  H3_Sw_Q670               2                                    

Full‐length HA sequences were established of the genome segment 4 of these viruses to align oligonucleotide sequences of primers and probes. Sequences are available from the Epiflu database at GISAID: EPI734316, EPI734466 and EPI734318.
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While the isolates and clinical samples used here for validation purposes only represent a small fraction of the ongoing monitoring project, the comparatively large fraction of HA/NA reassortants is notable (Table [5](#irv12407-tbl-0005){ref-type="table-wrap"}, bold‐face samples). Increasing diversity of genotypes and HA/NA reassortant patterns, especially within subtype H1, has previously been noticed.[18](#irv12407-bib-0018){ref-type="ref"}, [21](#irv12407-bib-0021){ref-type="ref"}, [31](#irv12407-bib-0031){ref-type="ref"}, [41](#irv12407-bib-0041){ref-type="ref"} No reassortants were detected here for the H3 subtype.

Based on the results of this study, we propose an algorithm, depicted in Figure [1](#irv12407-fig-0001){ref-type="fig"}, for the detection and subtyping of porcine influenza viruses currently circulating in Europe. Any sample that tested positive in a generic influenza A virus RT‐qPCR (e.g. the modified Spackman M PCR enhanced with an internal control) is subjected in a second step to tetraplex HA‐ and triplex NA‐specific RT‐qPCRs which enable the delineation of four HA and three NA lineages/subtypes, respectively, of European SIV. In case either of these multiplex PCRs yields negative results, the subtype has to be determined by amplicon sequencing. The updated conventional pan‐HA‐SIV and the original pan‐NA RT‐PCRs previously developed by Gall et al.[33](#irv12407-bib-0033){ref-type="ref"} (2009) can be used as a complementing amplicon sequencing system. Alternatively, other published RT‐PCR protocols for the generation of lineage‐specific SIV HA and NA amplicons might be used.[28](#irv12407-bib-0028){ref-type="ref"}

![Proposed diagnostic algorithm for detection and subtyping of swine influenza viruses in Europe based on one‐step multiplex RT‐qPCRs. *Step 1* depicts an IAV‐generic one‐step RT‐qPCR, for example targeting the M gene segment; an internal control (IC2) is essentially included in this duplex RT‐qPCR. For IAV RNA‐positive samples, subtyping is attempted in *step 2* employing the one‐step tetraplex HA‐ and the triplex NA‐specific RT‐qPCRs developed in this study. Only for cases in which HA or NA subtype/lineage cannot be assigned by these RT‐qPCRs, *step 3* is required and HA and/or NA amplicons need to be generated by conventional one‐step RT‐PCR for Sanger amplicon sequencing and BLAST searches to finalize subtyping](IRV-10-504-g001){#irv12407-fig-0001}

The newly developed multiplex RT‐qPCRs provide basic tools for a sustained monitoring programme of swine influenza in Europe. In addition, virus isolation on selected samples is required to allow further antigenic, in‐depth genetic and biological characterizations of circulating virus strains.
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